syngeneintl.comContract Research | Contract Development And Manufacturing | Syngene CRO

-- End of the comment -- COVID-19 Updates InstaVisit Blog Contact Us Menu COVID-19 Updates InstaVisit Blog Contact Us About Us Executive Leadership Awards And Recognitions​ Certifications Quality Management Environment, Health, Safety & Sustainability Corporate Social Responsibility Solutions Small Molecules Large Molecules SynVent Integrated Drug Discovery Other Drug Modalities Industries Dedicated Centers Center for Advanced Protein Studies (CAPS) Discovery Chemistry Biology Safety Assessment Research Informatics Development Chemical Development Formulation Development Analytical Development Clinical Development Manufacturing Commercial Manufacturing Discovery molecular biology protein sciences Cell line development & analysis antibody generation Development & Manufacturing Development and Manufacturing Services Analytical Characterization & Quality Control Viral Testing & Clearance Bioanalytical Laboratory Services SynVent Integrated Drug Discovery Know More Know More Peptides Oligonucleotides Antibody Drug Conjugates PROTACs CAR-T Pharmaceutical & Biotech Animal Health Agrochemical Nutrition Specialty & Performance Chemicals/Others Dedicated Centers Know More Know More Center for Advanced Protein Studies (CAPS) Know More Know More Small Molecule List Item #1 List Item #2 List Item #3 List Item #1 List Item #2 List Item #3 List Item #1 List Item #2 List Item #3 Industries Dedicated Centres Center for Advanced Protein Studies (CAPS) Menu Small Molecule Chemistry Other Drug Modalities Large Molecule Industries Dedicated Centres Center for Advanced Protein Studies (CAPS) Investors Overview Investor Fact Sheet Financial Information Corporate Governance Governance Structure Board Of Directors Committees To The Board Our Leadership Corporate Structure Governance Reports & Policies Share Holder Services Stock Exchange Disclosures Analyst Coverage Investor Calendar Investor Contact Careers News & Events Press Release In the Media Events Insights & Resources Group Companies Biocon Biocon Biologics BICARA Biocon Academy Menu About Us Executive Leadership Awards And Recognitions​ Certifications Quality Management Environment, Health, Safety & Sustainability Corporate Social Responsibility Solutions Small Molecules Discovery Chemistry Biology Safety Assessment Research Informatics Development Chemical development Formulation development Clinical Development Analytical Development Manufacturing Commercial Manufacturing Large Molecules Discovery Molecular Biology Protein Sciences Cell Line Development & Analysis Antibody Generation Development & Manufacturing Development and Manufacturing Services Analytical Characterization & Quality Control Viral Testing & Clearance Bioanalytical Laboratory Services Synvent Integrated Drug Discovery Other Drug Modalities Peptides Oligonucleotides Antibody Drug Conjugates PROTACs CAR-T Industries Dedicated Centers Center For Advanced Protein Studies (CAPS) Investors Overview Corporate Governance Financial Information Share holder services Investor Calendar Investor Contact Careers News & Events Press Release In the Media Events Insights & Resources Group Companies Biocon Biocon Biologics BICARA Biocon Academy COVID-19 Updates InstaVisit Blog Contact Us Search Close Drug Repurposing — Perspective on an emerging pharmaceutical solution How drug repurposing can be an effective alternative approach to traditional methods of drug discovery Register Now Register Now We have adapted to the COVID-19 ‘New Normal’ Rigorous testing, safety monitoring, zoning measures, social distancing at work, adopting digital measures, BCP – our robust COVID-19 controls enables us to continue to operate efficiently More More Transforming research to sustainable business We are the partner of choice for over 360 organizations globally More More Research that changes the world for the better We are accelerating drug innovation and development for companies globally More More Who we are We are an innovation-led contract research, development and manufacturing organization offering integrated scientific services from early discovery to commercial supply. More More What we do We offer clients a customized end-to-end solution to fulfil their R&D and manufacturing requirements. Our approach enables us to forge client relationships that move beyond the traditional service outsourcing model into true end-to-end collaborations. Discovery Our Discovery Services span the entire spectrum of early stage research from target … More More Development Our Development Services encompass activities from pre-clinical to clinical trials… More More Manufacturing Our Manufacturing services include cGMP-compliant facilities for clinical supplies, registration batches… More More Dedicated Centers Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support… More More InstaVisit - Visit Syngene Virtually Syngene InstaVisit is an interactive virtual experience designed to give you a 360 degree view of Syngene’s world-class facilities and capabilities. The platform allows you to change your perspective, look around and zoom in as we take you on a guided tour of Syngene’s labs. View Now View Now 0 Clients 0 Collaborations with the top 10 Pharma/Biotech companies 0 + Experienced Scientists 0 Mn sq. ft. of R&D and manufacturing infrastructure 0 + Patents Latest news View all View all Syngene announces Q3 FY21 results More Press Release 20th Jan, 2021 Syngene and PharmAust collaborate to manufacture GMP-grade Monepantel for Human Clinical Trials More Press Release 23rd Dec, 2020 Syngene & Deerfield – Financial Times More News 19th Nov, 2020 Insights View all View all Dedicated R&D Centres – The Next Step In The Pharma Outsourcing Model With wide-ranging capabilities in biology, we offer high quality, seamless and cost effective… More 22 September 2020 Syngene’s Supply Chain Management Improves Efficiency With wide-ranging capabilities in biology, we offer high quality, seamless and cost effective… More 22 September 2020 Syngene Viral Testing Facility – Striving for Excellence With wide-ranging capabilities in biology, we offer high quality, seamless and cost effective… More 22 September 2020 Upcoming events View all View all Virtual Symposium: Targeted Protein Degradation & PROTAC 16th - 17th Feb, 2021 Virtual Book Now Precision in Drug Discovery & Preclinical Virtual Summit (West Coast) 3rd - 4th Mar, 2021 Virtual Book Now Corporate social responsibility To strive towards developing and sustaining healthy and empowered communities by improving the quality of life. More More Syngene International Ltd +1.35(0.32%) +1.35(0.32%) Governance Behind consistent growth is good governance More More Careers Discover a world of opportunities More More Annual Reports Touching a billon lives through innnovation More More Enter your email id and sign-up for our newsletter Subscribe © 2021. Syngene International Limited Twitter Linkedin-in Youtube Facebook-f Quick Links About Us Investors Careers News & Events Insights & Resources COVID-19 Updates InstaVisit Business Discovery Development Manufacturing SynVent Integrated Drug Discovery Industries Dedicated Centers Center For Advanced Protein Studies (CAPS) Get In Touch Contact Us Investor Contact Other Links Disclaimer Privacy Policy Cookie Policy Twitter Linkedin-in Youtube Facebook-f © 2021. Syngene International Limited...